AMATHold
Applied Materials
Price (1y)
Fair price check
6 different valuation methods each estimate what AMAT should be worth, then we compare to today's price.
- P/E multiplesOvervaluedthinks it's expensive — estimates $346.75, about 21% below today
- P/B multiplesOvervaluedthinks it's expensive — estimates $265.85, about 39% below today
- EV/EBITDAOvervaluedthinks it's expensive — estimates $253.66, about 42% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $95.05, about 78% below today
- Residual IncomeOutlierestimate looks unreliable — estimates $69.67 — likely unreliable
- Graham (defensive)Outlierestimate looks unreliable — estimates $65.33 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $65.33 |
| P/E multiples(vs sector peers) | $346.75 |
| P/B multiples(vs sector peers) | $265.85 |
| EV/EBITDA(vs sector peers) | $253.66 |
| Residual Income | $69.67 |
| DCF (2-stage) | $95.05 |
- extreme graham estimate
- extreme rim estimate
Median of all applicable methods (current price $436.62). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency71Strong
- ValuePrice vs fundamentals32Weak
- GrowthRevenue & earnings trajectory51Decent
- MomentumRecent price strength93Strong
- HealthBalance sheet & solvency89Strong
- ProfitabilityROE, ROA, ROIC66Decent
- TechnicalTrend & volatility signals60Decent
- RiskVolatility & drawdown profile52Decent
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $346.51B |
| Revenue (TTM) | $28.21B |
| Net income (TTM) | $7.84B |
| Operating cash flow (TTM) | $8.72B |
| CapEx (TTM) | $2.52B |
| Free cash flow (TTM)CFO − CapEx | $6.19B |
| Total assets | $37.64B |
| Total liabilities | $15.93B |
| Stockholders' equity | $21.72B |
| Cash & equivalents | $7.22B |
| Shares outstanding | 793.61M |
| EPS (basic) | $2.55 |
| EPS (diluted) | $2.54 |
| P/E ratio (TTM) | 44.20 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-02-19
- Latest period end
- 2026-01-25
- Filing lag
- 86 days
- Missing metrics
- none
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.